By Dean Seal
Shares of Clover Health Investments jumped after regulators raised their rating of the company's primary healthcare plan.
The stock was up 19% at $5.12 on Wednesday. Shares have doubled since the start of the year.
The healthcare and technology company said before the opening bell that after it won a legal challenge last month on the Centers for Medicare & Medicaid Services' previous 3.5 star rating, the agency has recalculated and provided it a 4.5 star rating.
The star rating indicates the government's assessment of the quality and clinical outcomes of a provider's PPO Medicare Advantage plan. Clover's PPO plan covers over 97% of its members.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
June 10, 2026 12:14 ET (16:14 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.